Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondroitin Sulfates | 6 | 2012 | 23 | 1.620 |
Why?
|
| Superoxide Dismutase-1 | 7 | 2022 | 48 | 1.400 |
Why?
|
| Oligosaccharides | 4 | 2012 | 33 | 0.920 |
Why?
|
| Aging | 6 | 2021 | 976 | 0.900 |
Why?
|
| Inflammation | 9 | 2024 | 626 | 0.820 |
Why?
|
| Animals | 35 | 2024 | 10399 | 0.750 |
Why?
|
| Mice | 25 | 2024 | 4645 | 0.740 |
Why?
|
| Cartilage | 5 | 2012 | 37 | 0.730 |
Why?
|
| Insulin Resistance | 5 | 2024 | 176 | 0.720 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 329 | 0.710 |
Why?
|
| Mitochondria | 7 | 2022 | 366 | 0.700 |
Why?
|
| Epitopes | 4 | 2012 | 179 | 0.670 |
Why?
|
| Proteoglycans | 4 | 2010 | 38 | 0.610 |
Why?
|
| Obesity | 4 | 2024 | 668 | 0.600 |
Why?
|
| Aging, Premature | 1 | 2018 | 3 | 0.590 |
Why?
|
| Caloric Restriction | 2 | 2018 | 73 | 0.550 |
Why?
|
| Endopeptidase Clp | 2 | 2018 | 9 | 0.540 |
Why?
|
| Neurons | 2 | 2024 | 282 | 0.520 |
Why?
|
| Adiponectin | 3 | 2011 | 29 | 0.490 |
Why?
|
| Mitochondrial Proteins | 4 | 2018 | 72 | 0.450 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2011 | 162 | 0.450 |
Why?
|
| Lactates | 1 | 2024 | 19 | 0.440 |
Why?
|
| Mice, Knockout | 11 | 2022 | 845 | 0.410 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2012 | 1 | 0.400 |
Why?
|
| Animal Fins | 1 | 2012 | 2 | 0.400 |
Why?
|
| Brain | 5 | 2021 | 739 | 0.390 |
Why?
|
| Adipose Tissue, White | 3 | 2018 | 16 | 0.370 |
Why?
|
| Carrier Proteins | 3 | 2009 | 252 | 0.370 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 67 | 0.360 |
Why?
|
| Mitochondria, Muscle | 2 | 2015 | 43 | 0.360 |
Why?
|
| Membrane Proteins | 4 | 2018 | 485 | 0.350 |
Why?
|
| Electron Transport Complex IV | 3 | 2017 | 40 | 0.350 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2022 | 131 | 0.340 |
Why?
|
| Motor Neurons | 2 | 2022 | 44 | 0.340 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 166 | 0.330 |
Why?
|
| Antioxidants | 2 | 2002 | 225 | 0.320 |
Why?
|
| Sharks | 4 | 2012 | 7 | 0.310 |
Why?
|
| Liver | 3 | 2021 | 434 | 0.300 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1461 | 0.300 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 22 | 0.300 |
Why?
|
| Sarcopenia | 1 | 2018 | 42 | 0.290 |
Why?
|
| Necrosis | 1 | 2018 | 82 | 0.290 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 49 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 1570 | 0.280 |
Why?
|
| Growth Substances | 2 | 2004 | 11 | 0.280 |
Why?
|
| Epididymis | 1 | 2017 | 5 | 0.280 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 29 | 0.280 |
Why?
|
| Fish Oils | 1 | 2017 | 12 | 0.280 |
Why?
|
| Polysaccharides | 1 | 2007 | 63 | 0.270 |
Why?
|
| Homeostasis | 1 | 2018 | 117 | 0.270 |
Why?
|
| Frailty | 1 | 2017 | 19 | 0.270 |
Why?
|
| Unfolded Protein Response | 5 | 2018 | 25 | 0.270 |
Why?
|
| Interleukin-10 | 1 | 2017 | 71 | 0.260 |
Why?
|
| Protein Binding | 5 | 2013 | 656 | 0.260 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 521 | 0.260 |
Why?
|
| Myoblasts | 1 | 2015 | 8 | 0.250 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2007 | 54 | 0.250 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 633 | 0.250 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2007 | 129 | 0.250 |
Why?
|
| Cellular Senescence | 3 | 2022 | 125 | 0.240 |
Why?
|
| Plant Oils | 2 | 2002 | 10 | 0.240 |
Why?
|
| Biomarkers | 4 | 2022 | 755 | 0.240 |
Why?
|
| Vitamin A | 2 | 2002 | 25 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2010 | 28 | 0.230 |
Why?
|
| Protein Kinases | 3 | 2024 | 158 | 0.230 |
Why?
|
| beta Carotene | 2 | 2002 | 4 | 0.230 |
Why?
|
| Heparitin Sulfate | 1 | 2004 | 14 | 0.230 |
Why?
|
| Oxidative Stress | 4 | 2021 | 663 | 0.230 |
Why?
|
| Apoptosis | 1 | 2018 | 771 | 0.230 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 33 | 0.220 |
Why?
|
| Fibrosis | 2 | 2021 | 133 | 0.220 |
Why?
|
| Adipose Tissue | 3 | 2024 | 184 | 0.210 |
Why?
|
| Models, Animal | 2 | 2018 | 128 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 145 | 0.210 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2011 | 43 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 22 | 0.200 |
Why?
|
| Dietary Supplements | 2 | 2002 | 239 | 0.200 |
Why?
|
| Cell Proliferation | 1 | 2015 | 804 | 0.200 |
Why?
|
| Fatty Liver | 2 | 2018 | 57 | 0.200 |
Why?
|
| Heparin | 1 | 2002 | 110 | 0.190 |
Why?
|
| Vitamin A Deficiency | 1 | 2002 | 9 | 0.190 |
Why?
|
| Caenorhabditis elegans | 1 | 2002 | 58 | 0.190 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 62 | 0.190 |
Why?
|
| Cytokines | 1 | 2004 | 445 | 0.190 |
Why?
|
| Glycosaminoglycans | 1 | 2002 | 54 | 0.190 |
Why?
|
| Cell Line | 3 | 2024 | 694 | 0.190 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 11 | 0.190 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 87 | 0.190 |
Why?
|
| Cytosol | 1 | 2011 | 47 | 0.180 |
Why?
|
| Neuronal Plasticity | 2 | 2010 | 50 | 0.180 |
Why?
|
| Protein Kinase C | 1 | 2011 | 73 | 0.180 |
Why?
|
| Xerophthalmia | 1 | 2001 | 1 | 0.180 |
Why?
|
| Diet, High-Fat | 3 | 2024 | 136 | 0.180 |
Why?
|
| Male | 9 | 2018 | 13487 | 0.180 |
Why?
|
| Uronic Acids | 2 | 2012 | 4 | 0.170 |
Why?
|
| Extracellular Space | 1 | 2010 | 26 | 0.170 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 43 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2017 | 1433 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2009 | 1 | 0.160 |
Why?
|
| Longevity | 2 | 2018 | 134 | 0.160 |
Why?
|
| Nerve Net | 1 | 2010 | 106 | 0.160 |
Why?
|
| Interleukin-6 | 2 | 2019 | 193 | 0.160 |
Why?
|
| Muscles | 1 | 2009 | 73 | 0.160 |
Why?
|
| Acceleration | 1 | 2018 | 17 | 0.150 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 242 | 0.140 |
Why?
|
| Geriatrics | 1 | 2018 | 47 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2017 | 118 | 0.130 |
Why?
|
| Adiposity | 1 | 2017 | 94 | 0.130 |
Why?
|
| Receptor, Insulin | 2 | 2017 | 94 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 272 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2018 | 398 | 0.120 |
Why?
|
| Glucose | 2 | 2024 | 203 | 0.120 |
Why?
|
| Carbohydrate Sequence | 2 | 2007 | 14 | 0.120 |
Why?
|
| Chromatography, Gel | 2 | 2007 | 36 | 0.120 |
Why?
|
| Disaccharides | 2 | 2006 | 21 | 0.110 |
Why?
|
| Hydrogen Peroxide | 3 | 2015 | 144 | 0.110 |
Why?
|
| Cell Death | 1 | 2024 | 118 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2015 | 198 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2013 | 9 | 0.100 |
Why?
|
| Memory | 1 | 2013 | 73 | 0.100 |
Why?
|
| Flavonoids | 1 | 2013 | 33 | 0.100 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 33 | 0.100 |
Why?
|
| Humans | 10 | 2024 | 28121 | 0.100 |
Why?
|
| Arecaceae | 1 | 2002 | 1 | 0.100 |
Why?
|
| Peroxidases | 1 | 2002 | 6 | 0.100 |
Why?
|
| Acetylgalactosamine | 1 | 2012 | 2 | 0.100 |
Why?
|
| Purkinje Cells | 1 | 2012 | 7 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1050 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 24 | 0.100 |
Why?
|
| Kinetics | 2 | 2004 | 545 | 0.100 |
Why?
|
| Sulfates | 1 | 2012 | 91 | 0.100 |
Why?
|
| Female | 5 | 2018 | 15156 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 229 | 0.090 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 2007 | 3 | 0.080 |
Why?
|
| Rats | 3 | 2010 | 1564 | 0.080 |
Why?
|
| Oxygen Consumption | 3 | 2017 | 181 | 0.080 |
Why?
|
| Cholesterol | 2 | 2024 | 200 | 0.080 |
Why?
|
| Age Factors | 2 | 2018 | 733 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2018 | 82 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 29 | 0.070 |
Why?
|
| Models, Biological | 2 | 2011 | 465 | 0.070 |
Why?
|
| Static Electricity | 1 | 2007 | 35 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 133 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2007 | 67 | 0.070 |
Why?
|
| Carbohydrate Conformation | 1 | 2007 | 11 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2007 | 14 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 257 | 0.070 |
Why?
|
| Sheep | 1 | 2007 | 100 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 66 | 0.070 |
Why?
|
| Physical Endurance | 1 | 2017 | 91 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2006 | 22 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2018 | 198 | 0.060 |
Why?
|
| Biochemistry | 1 | 2006 | 10 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2018 | 311 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 133 | 0.060 |
Why?
|
| Cell Shape | 1 | 2015 | 16 | 0.060 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 12 | 0.060 |
Why?
|
| Body Composition | 1 | 2018 | 265 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 24 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2017 | 204 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 110 | 0.060 |
Why?
|
| Glycolysis | 1 | 2015 | 85 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2017 | 230 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2010 | 7 | 0.060 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2017 | 62 | 0.060 |
Why?
|
| Syndecans | 1 | 2004 | 2 | 0.060 |
Why?
|
| Syndecan-4 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Syndecan-1 | 1 | 2004 | 13 | 0.060 |
Why?
|
| Time Factors | 2 | 2002 | 1593 | 0.060 |
Why?
|
| Fructose | 1 | 2024 | 22 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2006 | 209 | 0.050 |
Why?
|
| Insulin | 2 | 2018 | 315 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 21 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 362 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2014 | 118 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 543 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2015 | 407 | 0.050 |
Why?
|
| Paralysis | 1 | 2022 | 10 | 0.050 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Biotinylation | 1 | 2002 | 19 | 0.050 |
Why?
|
| Decapodiformes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Dasatinib | 1 | 2022 | 18 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 14 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 23 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 247 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 70 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2002 | 5 | 0.050 |
Why?
|
| Genome | 1 | 2002 | 57 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 19 | 0.050 |
Why?
|
| Serine | 1 | 2011 | 49 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2011 | 50 | 0.050 |
Why?
|
| Palm Oil | 1 | 2001 | 1 | 0.050 |
Why?
|
| Metformin | 1 | 2011 | 36 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 413 | 0.050 |
Why?
|
| Protein Transport | 1 | 2011 | 157 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2011 | 267 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 605 | 0.040 |
Why?
|
| India | 1 | 2001 | 143 | 0.040 |
Why?
|
| Sensory Deprivation | 1 | 2010 | 5 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2021 | 273 | 0.040 |
Why?
|
| Visual Cortex | 1 | 2010 | 8 | 0.040 |
Why?
|
| Darkness | 1 | 2010 | 17 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2001 | 77 | 0.040 |
Why?
|
| Phenotype | 1 | 2022 | 679 | 0.040 |
Why?
|
| Axons | 1 | 2010 | 24 | 0.040 |
Why?
|
| Visual Perception | 1 | 2010 | 45 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2010 | 63 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2011 | 575 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2002 | 336 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 47 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 20 | 0.040 |
Why?
|
| Aldehydes | 1 | 2019 | 55 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 70 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 112 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2001 | 722 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 140 | 0.040 |
Why?
|
| Receptors, Adiponectin | 1 | 2008 | 5 | 0.040 |
Why?
|
| Infant | 1 | 2002 | 996 | 0.040 |
Why?
|
| Calcium | 1 | 2009 | 235 | 0.040 |
Why?
|
| Hippocampus | 1 | 2019 | 189 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 1137 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 48 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2017 | 26 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 120 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 26 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 149 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2002 | 2380 | 0.030 |
Why?
|
| Kidney | 1 | 2016 | 285 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2014 | 23 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 62 | 0.030 |
Why?
|
| Superoxides | 1 | 2014 | 61 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 633 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 121 | 0.030 |
Why?
|
| Maze Learning | 1 | 2013 | 78 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 64 | 0.030 |
Why?
|
| Myocardium | 1 | 2014 | 192 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 61 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 51 | 0.030 |
Why?
|
| Heart | 1 | 2014 | 223 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2002 | 31 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2012 | 29 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2013 | 107 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2002 | 17 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2013 | 110 | 0.030 |
Why?
|
| Solubility | 1 | 2002 | 73 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2002 | 119 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 180 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2002 | 57 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2013 | 161 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 95 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2002 | 114 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 267 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2002 | 87 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 462 | 0.020 |
Why?
|
| Melanoma | 1 | 2013 | 153 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 369 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 848 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1324 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 825 | 0.020 |
Why?
|
| Neurocan | 1 | 2006 | 1 | 0.020 |
Why?
|
| Brevican | 1 | 2006 | 1 | 0.020 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Aggrecans | 1 | 2006 | 5 | 0.020 |
Why?
|
| Buffers | 1 | 2006 | 24 | 0.020 |
Why?
|
| Streptomyces | 1 | 2006 | 11 | 0.020 |
Why?
|
| Detergents | 1 | 2006 | 24 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 43 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 153 | 0.010 |
Why?
|